Report Detail
Global Drug Eluting Balloon for Peripheral Artery Disease Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4671899 |
- 10 February, 2026 |
- Global |
- 96 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Drug Eluting Balloon for Peripheral Artery Disease market size was valued at US$ 834 million in 2025 and is forecast to a readjusted size of US$ 1799 million by 2032 with a CAGR of 11.4% during review period.
Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing “limus” exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a “leave nothing behind” concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability—often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD—supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.
The hurdle is no longer “can you launch,” but “can you scale with reproducibility and compliant delivery.” As drug–device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability—where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization—lesion preparation, drug-transfer efficiency, and durable patency—driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from “operator preference–driven” toward “pathway management–driven” growth—where evidence communication, technique standardization, and supply reliability matter more than ever.
Upstream differentiation is ultimately an integrated “materials–coating–validation” capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or “limus” agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.
This report is a detailed and comprehensive analysis for global Drug Eluting Balloon for Peripheral Artery Disease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Eluting Balloon for Peripheral Artery Disease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Drug Eluting Balloon for Peripheral Artery Disease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Drug Eluting Balloon for Peripheral Artery Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Drug Eluting Balloon for Peripheral Artery Disease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Eluting Balloon for Peripheral Artery Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Eluting Balloon for Peripheral Artery Disease market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drug Eluting Balloon for Peripheral Artery Disease market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Iliac Artery
Femoropopliteal
Other
Market segment by Use Scenario
In-Stent Restenosi
De Novo
Small Vessel
Market segment by Balloon Platform Mechanics
Semi-/Compliant
Non-compliant
Other
Market segment by Application
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Major players covered
Medtronic
Boston Scientific
BD
Acotec
Philips
Lepu Medical
Eurocor
MicroPort Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Balloon for Peripheral Artery Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, with price, sales quantity, revenue, and global market share of Drug Eluting Balloon for Peripheral Artery Disease from 2021 to 2026.
Chapter 3, the Drug Eluting Balloon for Peripheral Artery Disease competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Balloon for Peripheral Artery Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug Eluting Balloon for Peripheral Artery Disease market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Balloon for Peripheral Artery Disease.
Chapter 14 and 15, to describe Drug Eluting Balloon for Peripheral Artery Disease sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Iliac Artery
- 1.3.3 Femoropopliteal
- 1.3.4 Other
- 1.4 Market Analysis by Use Scenario
- 1.4.1 Overview: Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Use Scenario: 2021 Versus 2025 Versus 2032
- 1.4.2 In-Stent Restenosi
- 1.4.3 De Novo
- 1.4.4 Small Vessel
- 1.5 Market Analysis by Balloon Platform Mechanics
- 1.5.1 Overview: Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Balloon Platform Mechanics: 2021 Versus 2025 Versus 2032
- 1.5.2 Semi-/Compliant
- 1.5.3 Non-compliant
- 1.5.4 Other
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals
- 1.6.3 Ambulatory Surgery Centers
- 1.6.4 Catheterization Laboratories
- 1.6.5 Others
- 1.7 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size & Forecast
- 1.7.1 Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity (2021-2032)
- 1.7.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.1.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Medtronic Recent Developments/Updates
- 2.2 Boston Scientific
- 2.2.1 Boston Scientific Details
- 2.2.2 Boston Scientific Major Business
- 2.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.2.4 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Boston Scientific Recent Developments/Updates
- 2.3 BD
- 2.3.1 BD Details
- 2.3.2 BD Major Business
- 2.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.3.4 BD Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 BD Recent Developments/Updates
- 2.4 Acotec
- 2.4.1 Acotec Details
- 2.4.2 Acotec Major Business
- 2.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.4.4 Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Acotec Recent Developments/Updates
- 2.5 Philips
- 2.5.1 Philips Details
- 2.5.2 Philips Major Business
- 2.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.5.4 Philips Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Philips Recent Developments/Updates
- 2.6 Lepu Medical
- 2.6.1 Lepu Medical Details
- 2.6.2 Lepu Medical Major Business
- 2.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.6.4 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Lepu Medical Recent Developments/Updates
- 2.7 Eurocor
- 2.7.1 Eurocor Details
- 2.7.2 Eurocor Major Business
- 2.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.7.4 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Eurocor Recent Developments/Updates
- 2.8 MicroPort Medical
- 2.8.1 MicroPort Medical Details
- 2.8.2 MicroPort Medical Major Business
- 2.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product and Services
- 2.8.4 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 MicroPort Medical Recent Developments/Updates
3 Competitive Environment: Drug Eluting Balloon for Peripheral Artery Disease by Manufacturer
- 3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Manufacturer (2021-2026)
- 3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Drug Eluting Balloon for Peripheral Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Drug Eluting Balloon for Peripheral Artery Disease Manufacturer Market Share in 2025
- 3.4.3 Top 6 Drug Eluting Balloon for Peripheral Artery Disease Manufacturer Market Share in 2025
- 3.5 Drug Eluting Balloon for Peripheral Artery Disease Market: Overall Company Footprint Analysis
- 3.5.1 Drug Eluting Balloon for Peripheral Artery Disease Market: Region Footprint
- 3.5.2 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Type Footprint
- 3.5.3 Drug Eluting Balloon for Peripheral Artery Disease Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region
- 4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Region (2021-2032)
- 4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Region (2021-2032)
- 4.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Region (2021-2032)
- 4.2 North America Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021-2032)
- 4.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021-2032)
- 4.4 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021-2032)
- 4.5 South America Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021-2032)
- 4.6 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Type (2021-2032)
- 5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 6.2 Global Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Application (2021-2032)
- 6.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Application (2021-2032)
7 North America
- 7.1 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 7.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 7.3 North America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country
- 7.3.1 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Country (2021-2032)
- 7.3.2 North America Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 8.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 8.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country
- 8.3.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region
- 9.3.1 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 10.2 South America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 10.3 South America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country
- 10.3.1 South America Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Country (2021-2032)
- 10.3.2 South America Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country
- 11.3.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers
- 12.2 Drug Eluting Balloon for Peripheral Artery Disease Market Restraints
- 12.3 Drug Eluting Balloon for Peripheral Artery Disease Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Drug Eluting Balloon for Peripheral Artery Disease and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Drug Eluting Balloon for Peripheral Artery Disease
- 13.3 Drug Eluting Balloon for Peripheral Artery Disease Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Drug Eluting Balloon for Peripheral Artery Disease Typical Distributors
- 14.3 Drug Eluting Balloon for Peripheral Artery Disease Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Drug Eluting Balloon for Peripheral Artery Disease. Industry analysis & Market Report on Drug Eluting Balloon for Peripheral Artery Disease is a syndicated market report, published as Global Drug Eluting Balloon for Peripheral Artery Disease Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Drug Eluting Balloon for Peripheral Artery Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
